CHO Pharma, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 297,000 compared to TWD 290,000 a year ago. Operating loss was TWD 369.163 million compared to TWD 319.233 million a year ago. Net loss was TWD 358.372 million compared to TWD 306.569 million a year ago. Basic loss per share was TWD 1.96 compared to TWD 1.69 a year ago.